GlassScriptPhysician profile
Jason Lionel Andre
NPI 1821259706
$9,345.34
in general payments reported to CMS, 2019-2025
29 companies · $966 in 2025
The $966 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,617 · 2020: $620 · 2021: $432 · 2022: $349 · 2023: $1,316 · 2024: $3,047 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,996 · Travel and Lodging: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,995.66 |
| Travel and Lodging | $1,332.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,222.53 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $1,341.96 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $925.22 | 2020-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Medtronic, INC. | $910.37 | 2021-2025 | Endurant Iis, Abre, Heli-Fx Endoanchor System |
| Silk Road Medical, INC. | $840.48 | 2019 | |
| Smith+Nephew, INC. | $576.40 | 2019-2025 | Stravix Mesh, Grafix Pl, Stravix |
| Philips North America LLC | $334.70 | 2021-2025 | IV Other |
| Reflow Medical INC | $327.39 | 2024-2025 | |
| Penumbra, INC. | $278.83 | 2019-2023 | Indigo System |
| Kerecis Limited | $218.95 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Shockwave Medical, INC | $195.43 | 2023-2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardinal Health 200 LLC | $185.68 | 2020-2021 | |
| Cagent Vascular INC | $157.63 | 2025 | Serrantor |
| Boston Scientific Corporation | $148.52 | 2019-2024 | Eluvia |
| Acell, INC. | $115.61 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $100.92 | 2022-2025 | Rotarexs 6 F X 135 Cm |
| Janssen Pharmaceuticals, INC | $88.85 | 2019-2020 | |
| Cook Medical LLC | $62.24 | 2019 | |
| Tactile Systems Technology INC | $60.10 | 2019 | |
| Misonix INC | $59.80 | 2019 | |
| Baxter Healthcare | $45.89 | 2025 | Coseal |
| Lemaitre Vascular, INC. | $33.81 | 2025 | Xenosure Biologic Patch |
| Angiodynamics, INC. | $18.84 | 2023 | Auryon Laser System 100-120 Vac |
| Becton, Dickinson and Company | $18.23 | 2025 | Fluency Endovascular Stent Graft |
| Pfizer INC. | $17.77 | 2019 | |
| Siemens Medical Solutions USA, INC. | $16.28 | 2024 | Artis Q Floor |
| Kci USA, INC. | $15.70 | 2022 | |
| Merck Sharp & Dohme LLC | $15.46 | 2025 | Bridion |
| Cashflow Solutions, LLC | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Andre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.